The pharmaceutical industry is becoming increasingly global, complex, and competitive. Drug developers are no longer competing only on clinical efficacy. Regulatory speed, pricing and reimbursement, market access, clinical trial execution, partnerships, i ... もっと読む

The pharmaceutical industry is becoming increasingly complex as companies compete across drug development, clinical trials, regulatory approvals, commercialization, market access, and emerging therapeutic technologies. In this environment, Competitive Int ... もっと読む

The intratumoral cancer therapies market is entering a phase of rapid expansion. Valued at roughly USD 115 million across the seven major markets (US, EU4, UK, and Japan) in 2025, this space is projected to surge to nearly USD 4.19 billion by 2034, reflec ... もっと読む

↑このページのトップヘ